Comparative chemical evaluation of two commercially available derivatives of hyaluronic acid (hylaform from rooster combs and restylane from streptococcus) used for soft tissue augmentation.
Hyaluronic acid (HA) derivatives have been developed to try to enhance rheological properties of this molecule to make it suitable for various medical applications. The main dermatological application of HA derivatives is the augmentation of soft tissues, via injection into the dermis. HA derivatives are indicated for the correction of cutaneous contour deficiencies of the skin, particularly in cases of ageing or degenerative lesions or to increase lips. Two HA derivatives have been evaluated: Hylaform Viscoelastic Gel (Hylan B), derived from rooster combs and subjected to cross-linking, and Restylane, produced through bacterial fermentation (streptococci) and stabilized, as declared by the producer. In both cases the purpose is to improve HA theological characteristics and slow down its degradation once it is in contact with biological structures. Distribution of particle dimensions, pH, protein concentration and rheological properties have been investigated in order to evaluate their reliability as fillers for soft tissue augmentation. The results of the analyses showed that there are differences between Restylane and Hylaform. Especially as far as rheological characteristics are concerned, the results outline different structures of the products: Hylaform behaves as a strong hydrogel, Restylane as a weak hydrogel; rheologically Hylaform is clearly superior to Restylane. Hylaform contains a definitely minor quantity (about a quarter) of cross-linked hyaluronic acid than Restylane. Furthermore, although not declared by the manufacturer, Restylane contains protein, resulting from bacterial fermentation or added to enable cross-linking reaction; the quantity of proteins contained by Restylane can be as much as four times the quantity contained by Hylaform, for the same volume (1 ml). It is evident that Hylaform offers higher safety margin than Restylane. Furthermore, wide literature and 20 years of clinical experience on hyaluronan derived from rooster combs confirm the reliability of this derivative while we did not find evidence regarding about the safety of HA obtained from streptococcus.
Manna
F
F
Department of Chemical and Technological Studies of Biologically Active Substances, University La Sapienza, Rome, Italy.
Dentini
M
M
Desideri
P
P
De Pità
O
O
Mortilla
E
E
Maras
B
B
D000818:Animals; D001426:Bacterial Proteins / Q000032:analysis; D001672:Biocompatible Materials / Q000032:analysis* / Q000737:chemistry; D001673:Biodegradation, Environmental; D003129:Comb and Wattles; D003432:Cross-Linking Reagents / Q000737:chemistry; D003879:Dermatologic Agents / Q000032:analysis* / Q000737:chemistry; D005285:Fermentation; D006801:Humans; D006820:Hyaluronic Acid / Q000032:analysis* / Q000737:chemistry; D020136:Hydrogel, Polyethylene Glycol Dimethacrylate / Q000737:chemistry; D006863:Hydrogen-Ion Concentration; D007271:Injections, Intradermal; D008046:Lip / Q000473:pathology; D010316:Particle Size; D011506:Proteins / Q000032:analysis; D019651:Plastic Surgery Procedures; D012212:Rheology; D012449:Safety; D015595:Skin Aging / Q000473:pathology; D013291:Streptococcus
D001426:Bacterial Proteins; D001672:Biocompatible Materials; D003432:Cross-Linking Reagents; D003879:Dermatologic Agents; D011506:Proteins; D020136:Hydrogel, Polyethylene Glycol Dimethacrylate; D006820:Hyaluronic Acid